439 related articles for article (PubMed ID: 16265315)
1. Mechanisms of disease: roles of nitric oxide and endothelin-1 in delayed cerebral vasospasm produced by aneurysmal subarachnoid hemorrhage.
Suhardja A
Nat Clin Pract Cardiovasc Med; 2004 Dec; 1(2):110-6; quiz 2 p following 116. PubMed ID: 16265315
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage: putative mechanisms and novel approaches.
Kolias AG; Sen J; Belli A
J Neurosci Res; 2009 Jan; 87(1):1-11. PubMed ID: 18709660
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide metabolites in cisternal CSF correlate with cerebral vasospasm in patients with a subarachnoid haemorrhage.
Woszczyk A; Deinsberger W; Böker DK
Acta Neurochir (Wien); 2003 Apr; 145(4):257-63; discussion 263-4. PubMed ID: 12748885
[TBL] [Abstract][Full Text] [Related]
4. Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment.
Pluta RM
Pharmacol Ther; 2005 Jan; 105(1):23-56. PubMed ID: 15626454
[TBL] [Abstract][Full Text] [Related]
5. [Risk of cerebral vasospasm following subarachnoid hemorrhage is associated with endothelial nitric oxide synthase gene polymorphism].
Li P; Ma LT; Zhang XZ; Gong J; Mo XH
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Feb; 29(2):280-3. PubMed ID: 19246300
[TBL] [Abstract][Full Text] [Related]
6. New insights into the causes and therapy of cerebral vasospasm following subarachnoid hemorrhage.
Crowley RW; Medel R; Kassell NF; Dumont AS
Drug Discov Today; 2008 Mar; 13(5-6):254-60. PubMed ID: 18342802
[TBL] [Abstract][Full Text] [Related]
7. Delayed ischemia after subarachnoid hemorrhage: result of vasospasm alone or a broader vasculopathy?
Zemke D; Farooq MU; Mohammed Yahia A; Majid A
Vasc Med; 2007 Aug; 12(3):243-9. PubMed ID: 17848485
[TBL] [Abstract][Full Text] [Related]
8. New concepts regarding cerebral vasospasm: glial-centric mechanisms.
Mutch WA
Can J Anaesth; 2010 May; 57(5):479-89. PubMed ID: 20131107
[TBL] [Abstract][Full Text] [Related]
9. [Perspectives in the treatment of subarachnoid-hemorrhage-induced cerebral vasospasm].
Fandino J; Fathi AR; Graupner T; Jacob S; Landolt H
Neurocirugia (Astur); 2007 Feb; 18(1):16-27. PubMed ID: 17393042
[TBL] [Abstract][Full Text] [Related]
10. Does prophylactic postoperative hypervolemic therapy prevent cerebral vasospasm and improve clinical outcome after aneurysmal subarachnoid hemorrhage?
Capampangan DJ; Wellik KE; Aguilar MI; Demaerschalk BM; Wingerchuk DM
Neurologist; 2008 Nov; 14(6):395-8. PubMed ID: 19008746
[TBL] [Abstract][Full Text] [Related]
11. [Subarachnoid hemorrhage, cerebral ischemia and endothelin-1].
Secades JJ; Rubio E; Castellanos JM; de la Rosa MD; Mercadal J; Vilalta J; Catalán R; Galard RM
Rev Neurol; 2000 Jan 1-15; 30(1):27-34. PubMed ID: 10742992
[TBL] [Abstract][Full Text] [Related]
12. Inflammation and cerebral vasospasm after subarachnoid hemorrhage.
Pradilla G; Chaichana KL; Hoang S; Huang J; Tamargo RJ
Neurosurg Clin N Am; 2010 Apr; 21(2):365-79. PubMed ID: 20380976
[TBL] [Abstract][Full Text] [Related]
13. Role of Cyclooxygenase-2 in Relation to Nitric Oxide and Endothelin-1 on Pathogenesis of Cerebral Vasospasm After Subarachnoid Hemorrhage in Rabbit.
Munakata A; Naraoka M; Katagai T; Shimamura N; Ohkuma H
Transl Stroke Res; 2016 Jun; 7(3):220-7. PubMed ID: 27044361
[TBL] [Abstract][Full Text] [Related]
14. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
[TBL] [Abstract][Full Text] [Related]
15. Associations between endothelin polymorphisms and aneurysmal subarachnoid hemorrhage, clinical vasospasm, delayed cerebral ischemia, and functional outcome.
Griessenauer CJ; Starke RM; Foreman PM; Hendrix P; Harrigan MR; Fisher WS; Vyas NA; Lipsky RH; Lin M; Walters BC; Pittet JF; Mathru M
J Neurosurg; 2018 May; 128(5):1311-1317. PubMed ID: 28548598
[TBL] [Abstract][Full Text] [Related]
16. Endothelial nitric oxide synthase gene polymorphisms predict susceptibility to aneurysmal subarachnoid hemorrhage and cerebral vasospasm.
Khurana VG; Sohni YR; Mangrum WI; McClelland RL; O'Kane DJ; Meyer FB; Meissner I
J Cereb Blood Flow Metab; 2004 Mar; 24(3):291-7. PubMed ID: 15091109
[TBL] [Abstract][Full Text] [Related]
17. [Non-aneurysmal subarachnoid haemorrhage].
Bruder N
Ann Fr Anesth Reanim; 2007 Nov; 26(11):954-8. PubMed ID: 17936566
[TBL] [Abstract][Full Text] [Related]
18. Vasospasm in aneurysmal subarachnoid hemorrhage: diagnosis, prevention, and management.
Janardhan V; Biondi A; Riina HA; Sanelli PC; Stieg PE; Gobin YP
Neuroimaging Clin N Am; 2006 Aug; 16(3):483-96, viii-ix. PubMed ID: 16935712
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers and vasospasm after aneurysmal subarachnoid hemorrhage.
Jordan JD; Nyquist P
Neurosurg Clin N Am; 2010 Apr; 21(2):381-91. PubMed ID: 20380977
[TBL] [Abstract][Full Text] [Related]
20. Novel mechanism of endothelin-1-induced vasospasm after subarachnoid hemorrhage.
Xie A; Aihara Y; Bouryi VA; Nikitina E; Jahromi BS; Zhang ZD; Takahashi M; Macdonald RL
J Cereb Blood Flow Metab; 2007 Oct; 27(10):1692-701. PubMed ID: 17392694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
